Back

Clarifying relations of emotion regulation, emotional avoidance and anxiety symptoms in a community‐based treatment‐seeking sample.

  • Published In: Psychology & Psychotherapy: Theory, Research & Practice, 2024, v. 97, n. 2. P. 393 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Bock, Rachel C.; Baker, Lucas D.; Kalantar, Emily A.; Berghoff, Christopher R.; Stroman, Joel C.; Gratz, Kim L.; Tull, Matthew T. 3 of 3

Abstract

Objectives: Anxiety is a global problem that is readily treatable with psychosocial interventions, though many individuals do not benefit following participation in extant treatment protocols. Accordingly, clarification of process‐related variables that may be leveraged to enhance outcomes appears warranted. Emotion regulation (ER) is a robust correlate of anxiety symptoms and is often targeted in behavioural treatments applied to anxiety‐related problems. Yet, some evidence suggests ER difficulties may be a proxy variable for emotional avoidance (EA). Clarifying the relative influence of ER and EA on anxiety symptom severity may improve specificity in targeting behavioural processes within psychosocial treatments designed to alleviate anxiety‐related suffering. Accordingly, we examined relations of ER and EA to anxiety symptom severity after accounting for anxiety sensitivity and anxiolytic medication use in a community‐based treatment‐seeking sample. Design: A four‐step hierarchical linear regression analysis of cross‐sectional data provided by a community‐based treatment‐seeking sample. Methods: Totally, 120 participants (Mage = 39.18; Female = 58.3%) completed a questionnaire packet upon intake to an anxiety disorders clinic. Results: EA and ER were strongly correlated, and each accounted for significant variance over and above model covariates. EA was a dominant risk factor for anxiety symptom severity, as ER was not a significant predictor (p =.073) following the inclusion of EA in the model (p =.006). Conclusions: EA appears to be a dominant risk factor, and ER a proxy risk factor, for anxiety symptom severity. EA may be an avenue for greater treatment specificity for those with anxiety symptoms. [ABSTRACT FROM AUTHOR]

Additional Information

  • Source:Psychology & Psychotherapy: Theory, Research & Practice. 2024/06, Vol. 97, Issue 2, p393
  • Document Type:Article
  • Subject Area:Health and Medicine
  • Publication Date:2024
  • ISSN:1476-0835
  • DOI:10.1111/papt.12523
  • Accession Number:177146117
  • Copyright Statement:Copyright of Psychology & Psychotherapy: Theory, Research & Practice is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.